Salmon lice drug secures new funding

Jan Rune Nordhagen

Source: Thor Brødreskift

Sarsia and Coast Seafood inject NOK 12 million into Norwegian biotech company Vestland Pharma

Norwegian biotech company Vestland Pharma, which has patented a drug against salmon lice, has received fresh backing, with venture company Sarsia and the seafood company Coast Seafood becoming shareholders.

Continue this article…

Already subscribed? SIGN IN now

wf_web_image

Sign up for FREE to continue this article!

Want to read more before deciding on a subscription? It only takes a minute to sign up for a free account and you’ll get to enjoy:

  • Weekly newsletters providing valuable news and information on the commercial fishing and aquaculture sector
  • Full access to our news archive
  • Live and archived webinars, podcasts and videos
  • Articles on innovations and current trends in the commercial fishing industry
  • Our extensive archive of data, research and intelligence

Get more free content sign up today

Ready to subscribe? Choose from one of our subscription packages for unlimited access!